Massachusetts General researchers find treatment is effective against ROS1-positive lung cancer in a small trial

Treatment with the targeted therapy drug crizotinib effectively halted the growth of lung tumors driven by rearrangements of the ROS1 gene in a small clinical trial. …read more

Source: Cancer